Oorsprong van het eerstegraads netwerk van Heinz Boller
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Chemicals: Specialty | 7 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Heinz Boller via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| UBS | Investment Managers | Corporate Officer/Principal | |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| BACHEM HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Sunstar-Holding AG
 Sunstar-Holding AG Hotels/Resorts/Cruise linesConsumer Services Sunstar-Holding AG engages in the operation of holiday hotels. The company was founded by Fritz Buser and Ernst Rieder on March 14, 1969 and is headquartered in Liestal, Switzerland. | Hotels/Resorts/Cruise lines | Director/Board Member | |
Ingro Finanz AG
 Ingro Finanz AG Financial ConglomeratesFinance Ingro Finanz AG provides investment services. The company is based in Bubendorf, Switzerland. | Financial Conglomerates | Chairman | |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Investment Managers | Chief Executive Officer | |
GABA AG
 GABA AG Medical DistributorsDistribution Services GABA AG manufactures oral care products. Its brands include aronal, elmex and meridol. GABA develops its develops products in the field of dentistry, molecular biology, ergonomy, and others. The company was founded in 1917 by Dr. Hermann Geiger and is headquartered in Therwil, Switzerland. | Medical Distributors | Director/Board Member | |
| University of California, Santa Barbara | College/University | Chief Tech/Sci/R&D Officer | |
| University of Karlsruhe | College/University | Doctorate Degree | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Chief Administrative Officer | |
| University of Bern | College/University | Doctorate Degree | |
| Evolma Holding AG | Director/Board Member | ||
Systag System Technik AG
 Systag System Technik AG Medical SpecialtiesHealth Technology Systag System Technik AG specializes in laboratory automation. The private company is based in Ruschlikon, Switzerland. The Swiss company has been a leading partner for chemical and pharmaceutical production facilities worldwide since 1965. The CEO of the company is Marcel Haugg. | Medical Specialties | Director/Board Member | |
| SPEXIS AG | Pharmaceuticals: Major | Director/Board Member | |
| Kyoto University | College/University | Graduate Degree | |
| Bachem Bioscience, Inc. | Chief Operating Officer | ||
The Genetics Co., Inc.
 The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Chairman | |
Bachem Americas, Inc.
 Bachem Americas, Inc. Pharmaceuticals: MajorHealth Technology Bachem Americas, Inc. engages in development of pharmaceutical ingredients through solid-phase peptide synthesis. The company is headquartered in Torrance, CA. | Pharmaceuticals: Major | Chairman | |
Dottikon Exclusive Synthesis AG
 Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
Bachem AG
 Bachem AG Pharmaceuticals: MajorHealth Technology Bachem AG engages in the sale and distribution of active pharmaceutical ingredients and research grade products. The firm’s products include peptides and complex organic molecules, as well as new chemical entities and generic active pharmaceutical ingredients. It also focuses on peptide research and development, including custom peptide synthesis. The company was founded by Peter Grogg in 1971 and is headquartered in Bubendorf, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| Bachem Distribution Services Gmbh | Corporate Officer/Principal | ||
| Migros Verteilzentrum Suhr AG | Comptroller/Controller/Auditor | ||
scienceindustries
 scienceindustries Miscellaneous Commercial ServicesCommercial Services scienceindustries operates as Swiss Business Association Chemistry Pharma Life Sciences. The firm represents the economic and political interests of its member companies. It also promotes the global competitiveness of its member companies by promoting an innovation-friendly environment and providing services for its members. The company was founded on December 23, 1944 and is headquartered in Zurich, Switzerland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Fox-Chemicals GmbH | Corporate Officer/Principal | ||
| Nextech III GP AG | Director/Board Member | ||
Basel Chamber of Commerce
 Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business. | Miscellaneous Commercial Services | Director/Board Member | |
Bachem (U.K.) Ltd.
 Bachem (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Bachem Holding AG, Bachem (U.K.) Ltd. is a leading, British innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company is based in St. Helens, UK. The company's dedicated and experienced project leaders ensure the development and manufacturing of products through close collaboration with the project team. Whatever the needs for non-GMP products, Bachem can prepare compounds according to specifications in any scale. Founded in 1986, the company provides solutions for today and innovation for tomorrow. | Pharmaceuticals: Major | Chairman | |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member | |
| MFC Beteiligungs AG | Chairman Chairman | ||
| Nextech Holding AG | Chairman | ||
| Dottikon Es Management AG | Director/Board Member Director/Board Member Corporate Officer/Principal | ||
| Dottikon Es America, Inc. | Director/Board Member Chief Executive Officer | ||
| Aerzte Treuhand G Deragisch | Comptroller/Controller/Auditor | ||
Swiss Scientific Computing Center
 Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland. | Miscellaneous Commercial Services | Chief Executive Officer | |
Nextech Venture Principals Ltd.
 Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey. | Financial Conglomerates | Director/Board Member | |
| Rising Tide Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| Simplyscience Stiftung | Corporate Officer/Principal | ||
| Bachem Japan KK | Chairman | ||
| Simply Science Foundation | Chairman | ||
| 8stogg AG | Director/Board Member | ||
| Wemedoo AG | Chairman | ||
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Zwitserland | 37 |
| Verenigde Staten | 9 |
| Duitsland | 4 |
| Japan | 3 |
| Verenigd Koninkrijk | 2 |
Sectoraal
| Health Technology | 14 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 5 |
| Process Industries | 2 |
Operationeel
| Director/Board Member | 33 |
| Corporate Officer/Principal | 14 |
| Chairman | 14 |
| Chief Executive Officer | 5 |
| Doctorate Degree | 5 |
Sterkste connecties
| Insiders | |
|---|---|
| Alfred Scheidegger | 20 |
| Thomas Früh | 17 |
| Peter Grogg | 14 |
| Marlene Born | 8 |
| Stephan Kirschbaum | 7 |
| Emanuel Tschannen | 4 |
| Robert Hofer | 1 |
- Beurs
- Insiders
- Heinz Boller
- Bedrijfsconnecties
